D. E. Shaw & Co., Inc. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q2 2023$108,438
-90.9%
32,960
-80.9%
0.00%
-100.0%
Q4 2022$1,192,697
+172.3%
172,355
+149.1%
0.00%
Q3 2022$438,000
-84.8%
69,181
-90.0%
0.00%
-100.0%
Q2 2022$2,877,000
+9.4%
694,966
+28.2%
0.00%
+50.0%
Q1 2022$2,630,000
+324.9%
542,203
+775.3%
0.00%
Q4 2021$619,000
-63.4%
61,948
-30.1%
0.00%
-100.0%
Q3 2021$1,693,000
+164.5%
88,601
+343.0%
0.00%0.0%
Q2 2021$640,000
-87.9%
20,000
-88.6%
0.00%
-80.0%
Q1 2021$5,282,000
-60.2%
175,168
-42.8%
0.01%
-54.5%
Q4 2020$13,261,000
-40.4%
306,467
-25.7%
0.01%
-52.2%
Q3 2020$22,257,000
-16.2%
412,531
-5.2%
0.02%
-28.1%
Q2 2020$26,572,000
+402.0%
435,322
+278.0%
0.03%
+300.0%
Q1 2020$5,293,000
-85.1%
115,163
-71.5%
0.01%
-80.5%
Q4 2019$35,417,000
+49.3%
403,612
+56.3%
0.04%
+36.7%
Q3 2019$23,716,000
-23.9%
258,290
+5.5%
0.03%
-23.1%
Q2 2019$31,153,000
-7.8%
244,912
+14.1%
0.04%
-9.3%
Q1 2019$33,779,000
+36.6%
214,700
-13.9%
0.04%
+22.9%
Q4 2018$24,736,000
-36.5%
249,357
-6.5%
0.04%
-25.5%
Q3 2018$38,928,000
+27.9%
266,628
+37.4%
0.05%
+17.5%
Q2 2018$30,448,000
+2.1%
194,000
+11.0%
0.04%
-2.4%
Q1 2018$29,832,000
-18.7%
174,710
-15.2%
0.04%
-18.0%
Q4 2017$36,684,000
+78.2%
205,970
+37.4%
0.05%
+56.2%
Q3 2017$20,589,000
+269.5%
149,896
+182.6%
0.03%
+255.6%
Q2 2017$5,572,000
+358.2%
53,041
+296.4%
0.01%
+350.0%
Q1 2017$1,216,000
-60.6%
13,379
-73.2%
0.00%
-60.0%
Q4 2016$3,085,000
-33.1%
50,000
-26.5%
0.01%
-37.5%
Q3 2016$4,608,000
+112.8%
67,989
+36.0%
0.01%
+100.0%
Q2 2016$2,165,000
+1.9%
50,0000.0%0.00%0.0%
Q1 2016$2,125,000
-33.8%
50,0000.0%0.00%
-20.0%
Q4 2015$3,211,000
-54.2%
50,000
-39.0%
0.01%
-54.5%
Q3 2015$7,012,000
-46.3%
81,965
+5.7%
0.01%
-45.0%
Q2 2015$13,060,000
+280.5%
77,565
+172.9%
0.02%
+300.0%
Q1 2015$3,432,000
+66.9%
28,419
+26.8%
0.01%
+66.7%
Q4 2014$2,056,00022,4190.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders